Stroke victims could benefit from hormone therapy

A new Swedish study accepted for publication by the Journal of Clinical Endocrinology and Metabolis — a publication of The Endocrine Society — reported on 407 patients that had experienced a stroke in their lifetime. These patients have been followed for a period of two years after the stroke. Levels of a hormone called IGF-1 have been shown to be elevated in the patients who had the best recovery after stroke.